Literature DB >> 1344659

Heterogeneity of cytokine production by human malignant melanoma cells.

C A Armstrong1, D C Tara, C E Hart, A Köck, T A Luger, J C Ansel.   

Abstract

Recent investigations indicate that malignant melanoma cells can produce distinct cytokines. While differences in the production of single cytokines have been observed among different melanoma cell lines, the extent of variability in the production of single and multiple cytokines between individual melanoma cell lines has not been as thoroughly investigated. A heterogeneity in melanoma cell cytokine production could have important implications for the biology of this aggressive neoplasm since certain cytokines may act as autocrine growth factors or be potent modulators of host immune response to the developing tumor. The purpose of this study is to assess the cytokine production profile of two widely available human melanoma cell lines, A375 and G361. The A375 cell line constitutively expressed the mRNA for IL-1 alpha, IL-1 beta and PDGF-A, with increased expression of these cytokines after induction with PMA. GM-CSF mRNA was expressed by the A375 melanoma line only after induction with PMA. No IL-6 mRNA was detected in the A375 melanoma cell line. The cell culture supernatants from the A375 cells likewise contained a parallel increase in IL-1 activity as determined in the D10 bioassay and secreted GM-CSF and PDGF-AA as measured by ELISA. In contrast, the G361 cell line did not express IL-1, GM-CSF or PDGF-A mRNA (constitutively or after PMA induction) but expressed only IL-6 mRNA and secreted IL-6 activity after PMA induction. These results demonstrate a significant heterogeneity in the production of IL-1 alpha, IL-1 beta, IL-6, GM-CSF, and PDGF in two distinct melanoma cell lines. This study demonstrates that individual melanoma cell lines express and secrete multiple cytokines both constitutively and after stimulation with PMA. The immunodulating and mitogenic properties of these melanoma-derived cytokines may have implications in determining the biologic behavior of different malignant melanomas.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1344659     DOI: 10.1111/j.1600-0625.1992.tb00070.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  6 in total

1.  Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis.

Authors:  M Luca; S Huang; J E Gershenwald; R K Singh; R Reich; M Bar-Eli
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

2.  A possible growth factor role of IL-6 in neuroectodermal tumours.

Authors:  E Candi; R A Knight; A Spinedi; P Guerrieri; G Melino
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

3.  Successful establishment of uveal and conjunctival melanoma in vitro.

Authors:  M McNamara; S M Kennedy
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-04       Impact factor: 2.723

4.  Novel production of interleukin-1 receptor antagonist peptides in normal human cornea.

Authors:  M C Kennedy; J T Rosenbaum; J Brown; S R Planck; X Huang; C A Armstrong; J C Ansel
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

5.  Determination of granulocyte/macrophage-colony-stimulating factor secretion by human melanoma cells and its effects on human melanoma cell proliferation.

Authors:  D Schadendorf; M Worm; B M Czarnetzki
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

6.  Interleukin-1α associates with the tumor suppressor p53 following DNA damage.

Authors:  J Novak; B Zamostna; V Vopalensky; M Buryskova; L Burysek; D Doleckova; M Pospisek
Journal:  Sci Rep       Date:  2020-04-24       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.